Previous Article | Next Article ![]()
Infect. Immun., 03 1997, 1126-1130, Vol 65, No. 3
JS Chia, SW Lin, CS Yang and JY Chen
Human salivary immunoglobulin A (IgA) and serum IgG antibodies to the
Streptococcus mutans glucosyltransferases (Gtfs) and to a synthetic peptide
of 19 amino acids from a conserved region in the Gtfs (residues 435 to 453)
were determined in young adults by enzyme-linked immunosorbent assay.
Varying levels of antibody to Gtfs were detected in saliva or serum, with
significantly higher levels of antibody to GtfD than to GtfB/C or GtfC.
Anti-Gtf IgA levels in saliva did not correlate with those of IgG in serum.
Caries-free (CF) volunteers exhibited significantly higher salivary IgA
antibody levels to the peptide and to GtfB/C or GtfC than did the
caries-active (CA) subjects. Preincubation of CF saliva and serum with the
peptide inhibited the antibodies to the Gtfs in a dose-dependent manner,
whereas preincubation of the samples from the CA group resulted in only
partial inhibition. Our results indicated that this 19-amino-acid peptide
includes one of the major B-cell epitopes of Gtfs and that CF individuals
have higher titers of antibodies than CA subjects.
Copyright © 1997, American Society for Microbiology
Antigenicity of a synthetic peptide from glucosyltransferases of Streptococcus mutans in humans
Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Republic of China. chiajs@ntumc1.mc.ntu.edu.tw
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|